May 15, 2020 / 9:01 AM / 18 days ago

BRIEF-Orexo: Gesynta Pharma Announces Positive Results From Phase 1 Study For OX-MPI

May 15 (Reuters) - Orexo AB:

* OREXO’S PARTNER GESYNTA PHARMA ANNOUNCES POSITIVE RESULTS FROM PHASE 1 STUDY FOR OX-MPI

* OREXO’S PARTNER, GESYNTA PHARMA, TODAY ANNOUNCES POSITIVE PHASE I RESULTS FOR OX-MPI (GS-248) Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below